老年CKD患者衰弱与疾病分期的基线特征
GOAL试验的基线分析描述了240例衰弱老年CKD患者,中位衰弱指数0.39,随衰弱加重和CKD分期进展,生活质量评分更差。
要点
- 衰弱老年CKD患者中,衰弱越重生活质量越差。
- CKD分期越晚,生活质量评分越低。
- 该队列以白人、男性为主,平均年龄76.9岁。
核心结论
- 衰弱程度更重和CKD分期更晚的老年患者生活质量评分更差。
研究设计与样本
- 纳入衰弱老年CKD患者240例,衰弱指数>0.25,年龄≥65岁或原住民≥55岁。
主要发现
- 招募历时27个月,男性占55.7%,白人/欧洲裔占82.9%,平均年龄76.9岁(SD:6.6)。
- 中位衰弱指数为0.39(IQR:0.32-0.47)。
- 极重度衰弱者中位EQ-5D-5L为0.57(IQR:0.28-0.83),重度为0.85(IQR:0.67-0.92),中度为0.90(IQR:0.82-0.93),总体P<0.001。
- 重度CKD者中位EQ-5D-5L为0.79(IQR:0.40-0.89),中度CKD为0.87(IQR:0.73-0.92),P=0.001。
关键数值与推荐
- 衰弱指数>0.25定义为衰弱,中度>0.25-<0.36,重度0.36-<0.45,极重度≥0.45。
- CKD中度定义为3或4期,重度定义为5期或5D期。
临床怎么用
- 对老年CKD患者应评估衰弱程度与CKD分期,以识别生活质量较差的高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The GOAL trial, a cluster randomized controlled trial, investigated the effect of comprehensive geriatric assessment (CGA) on frail older people with chronic kidney disease (CKD). This paper describes the following: (i) participant baseline characteristics, and (ii) their relationship with CKD stage and frailty severity. METHODS: Sixteen kidney outpatient clinics (clusters) were randomly allocated 1:1 to CGA or usual care. Enrolled frail older people with CKD (Frailty Index [FI] > 0.25; aged ≥65 years or ≥55 if First Nations people) received the intervention allocated to their cluster. CKD was defined as moderate (stages 3 or 4) or severe (stage 5 or 5D), and frailty categorized as moderate (>0.25-<0.36), severe (0.36-<0.45) or very severe (≥0.45). Participant characteristics were analyzed using descriptive statistics. Statistical methods appropriate for type of outcome were used to describe the association of frailty and CKD categories with participant characteristics. RESULTS: Over a 27-month period, 240 people were recruited (55.7% male, 82.9% White/European). Mean age was 76.9 (SD: 6.6) years and median FI was 0.39 (interquartile range [IQR]: 0.32-0.47). The median EQ-5D-5L quality-of-life index score was worse in those with very severe frailty (0.57, IQR: 0.28-0.83) compared to severe frailty (0.85, IQR: 0.67-0.92) and moderate frailty (0.90, IQR: 0.82-0.93) (overall P < 0.001). Median EQ-5D-5L was also worse in those with severe CKD (0.79, IQR: 0.40-0.89), compared to moderate CKD (median 0.87, IQR: 0.73-0.92; P = 0.001). CONCLUSION: This cohort demonstrated poorer quality-of-life scores in those with more severe frailty and more advanced CKD.
引用
- Logan B, Pascoe EM, Viecelli AK, et al. Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD. Kidney Int Rep. 2024. PMID: 39810773. doi:10.1016/j.ekir.2024.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。